Article
31 Oct 2025
Ontario Pilot Program And PCPA New Negotiation Pathway Aim To Expedite Access To Breakthrough Cancer Treatments
AUTHORS CONTENT
Article
09 Jul 2025
Finalized PMPRB Guidelines Published
Article
04 Feb 2025
New PMPRB Draft Guidelines Outline Administrative Process For Excessive Price Hearing Recommendations
Article
01 Nov 2024
Evolving Pharmacy Landscape Signals More Stringent Regulatory Scrutiny Of "Patient Steering"
Article
02 Sep 2024
Boehringer Ingelheim Succeeds In Nintedanib PMNOC Action Against JAMP
Article
31 Jul 2024
Discussion Guide For PMPRB Phase 2 Consultations On New Guidelines Outlines Proposed New Framework For Patented Medicine Price Review
Article
06 May 2024
Celebrating World IP Day 2024
Article
02 Apr 2024
Generic Submissions Under Review List Will Identify Generic Filers
Article
03 Mar 2023
Federal Court Dismisses Takeda's Motion To Consolidate Two Dexlansoprazole PMNOC Actions Against Apotex
Article
26 Jan 2023
Federal Court Of Appeal Restores Minister Of Health's Decision To Grant RUZURGI NOC Despite FIRDAPSE Data Protection
Article
22 Nov 2022
Federal Court Of Appeal Upholds Obviousness Finding Re: Janssen's Abiraterone Acetate And Prednisone Combination Therapy Patent
Article
27 Sep 2022
Sandoz Granted Leave To Add New Allegations On Condition Of Trial Adjournment And Extension Of 24-month Stay
Article
28 Jun 2022
Federal Court Finds Janssen's Macitentan Combination Therapy Patent Valid
Article
31 May 2022
Competition Bureau Resolves Misleading Performance Claims Case
Article
31 Mar 2022
Federal Court Sets Aside Decision By The Minister Of Health To Issue RUZURGI NOC For The Second Time
Article
22 Feb 2022
PMPRB Releases Report On Expensive Drugs For Rare Diseases
Article
02 Oct 2021
Regulatory Amendments Provide Permanent Measures To Address Therapeutic Product Shortages
Article
02 Aug 2021
Federal Court Of Appeal Confirms Janssen's SPRAVATO Not Eligible For Data Protection
Article
02 Jul 2021
Federal Court Of Appeal Upholds Decision Allowing Taro To Plead Validity Attacks Beyond Notice Of Allegation
Article
04 May 2021
Transition Measures Released For Interim Order For COVID-19 Drugs